WFRF:(Persaud Shanta)
Search: WFRF:(Persaud Shanta) > (2016) > Imatinib prevents b...
- 1 of 1
- Previous record
- Next record
- To hitlist
Imatinib prevents beta cell death in vitro but does not improve islet transplantation outcome
-
- King, Aileen J. F. (author)
- Kings Coll London, Div Diabet & Nutr Sci, Diabet Res Grp, Guys Campus, London SE1 1UL, England.
-
- Griffiths, Lisa A. (author)
- Kings Coll London, Div Diabet & Nutr Sci, Diabet Res Grp, Guys Campus, London SE1 1UL, England.
-
- Persaud, Shanta J. (author)
- Kings Coll London, Div Diabet & Nutr Sci, Diabet Res Grp, Guys Campus, London SE1 1UL, England.
- show more...
- show less...
- Kings Coll London, Div Diabet & Nutr Sci, Diabet Res Grp, Guys Campus, London SE1 1UL, England Institutionen för medicinsk cellbiologi (creator_code:org_t)
- 2016-03-08
- 2016
- English.
- In: Upsala Journal of Medical Sciences. - : Uppsala Medical Society. - 0300-9734 .- 2000-1967. ; 121:2, s. 140-145
- Journal article (peer-reviewed)
Abstract
Subject headings
Close
- Introduction Improving islet transplantation outcome could not only bring benefits to individual patients but also widen the patient pool to which this life-changing treatment is available. Imatinib has previously been shown to protect beta cells from apoptosis in a variety of in vitro and in vivo models. The aim of this study was to investigate whether imatinib could be used to improve islet transplantation outcome. Methods Islets were isolated from C57BI/6 mice and pre-cultured with imatinib prior to exposure to streptozotocin and cytokines in vitro. Cell viability and glucose-induced insulin secretion were measured. For transplantation experiments, islets were pre-cultured with imatinib for either 72 h or 24 h prior to transplantation into streptozotocin-diabetic C57BI/6 mice. In one experimental series mice were also administered imatinib after islet transplantation. Results Imatinib partially protected islets from beta cell death in vitro. However, pre-culturing islets in imatinib or administering the drug to the mice in the days following islet transplantation did not improve blood glucose concentrations more than control-cultured islets. Conclusion Although imatinib protected against beta cell death from cytokines and streptozotocin in vitro, it did not significantly improve syngeneic islet transplantation outcome.
Subject headings
- MEDICIN OCH HÄLSOVETENSKAP -- Klinisk medicin -- Allmänmedicin (hsv//swe)
- MEDICAL AND HEALTH SCIENCES -- Clinical Medicine -- General Practice (hsv//eng)
Keyword
- Imatinib
- islet
- transplantation
Publication and Content Type
- ref (subject category)
- art (subject category)
Find in a library
- Upsala Journal of Medical Sciences (Search for host publication in LIBRIS)
To the university's database
- 1 of 1
- Previous record
- Next record
- To hitlist
Find more in SwePub
- By the author/editor
- King, Aileen J. ...
- Griffiths, Lisa ...
- Persaud, Shanta ...
- Jones, Peter M.
- Howell, Simon L.
- Welsh, Nils
- About the subject
-
- MEDICAL AND HEALTH SCIENCES
- MEDICAL AND HEAL ...
- and Clinical Medicin ...
- and General Practice
- Articles in the publication
- Upsala Journal o ...
- By the university
- Uppsala University
Search outside SwePub
- Extend your search to:
- Google Book Search
- Google Scholar
Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.
- Copyright © LIBRIS - National Library Systems
- LIBRIS.kb.se
